Neurexin 1 (NRXN1) splice isoform expression during human neocortical development and aging

Molecular Psychiatry

Volumn 21, Issue 5, 2016, Pages 701-706

  Jenkins, A K ^a,b   Paterson, C ^a,c   Wang, Y ^a,d   Hyde, T M ^d   Kleinman, J E ^d   Law, A J ^a,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUREXIN; NEUREXIN 1; NEUREXIN 1 ALPHA; NEUREXIN 1 BETA; UNCLASSIFIED DRUG; ISOPROTEIN; NERVE CELL ADHESION MOLECULE; NERVE PROTEIN; NRXN1 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; BIPOLAR DISORDER; CHILD; CONTROLLED STUDY; DORSOLATERAL PREFRONTAL CORTEX; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEOCORTEX; NERVE CELL DIFFERENTIATION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; VERY ELDERLY; COMPARATIVE STUDY; GROWTH, DEVELOPMENT AND AGING; INFANT; METABOLISM; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; BIPOLAR DISORDER; CELL ADHESION MOLECULES, NEURONAL; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEOCORTEX; NERVE TISSUE PROTEINS; PROTEIN ISOFORMS; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84937916250     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2015.107     Document Type: Article

References (50)

1. Autism Genome Project C, Szatmari P, Paterson AD, Zwaigenbaum L, Roberts W, Brian J et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 2007; 39: 319-328
2. Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, Skaug J et al. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet 2008; 82: 477-488
3. Glessner JT, Wang K, Cai G, Korvatska O, Kim CE, Wood S et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 2009; 459: 569-573
4. Bena F, Bruno DL, Eriksson M, van Ravenswaaij-Arts C, Stark Z, Dijkhuizen T et al. Molecular and clinical characterization of 25 individuals with exonic deletions of NRXN1 and comprehensive review of the literature. Am J Med Genet 2013; 162B: 388-403
5. Ching MS, Shen Y, Tan WH, Jeste SS, Morrow EM, Chen X et al. Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders. Am J Med Genet 2010; 153B: 937-947
6. Gregor A, Albrecht B, Bader I, Bijlsma EK, Ekici AB, Engels H et al. Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1. BMC Med Genet 2011; 12: 106
7. Tucker T, Zahir FR, Griffith M, Delaney A, Chai D, Tsang E et al. Single exonresolution targeted chromosomal microarray analysis of known and candidate intellectual disability genes. Eur J Hum Genet 2014; 22: 792-800
8. Kirov G, Gumus D, Chen W, Norton N, Georgieva L, Sari M et al. Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Hum Mol Genet 2008; 17: 458-465
9. Ikeda M, Aleksic B, Kirov G, Kinoshita Y, Yamanouchi Y, Kitajima T et al. Copy number variation in schizophrenia in the Japanese population. Biol Pyschiatry 2010; 67: 283-286
10. International Schizophrenia C. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008; 455: 237-241
11. Need AC, Keefe RS, Ge D, Grossman I, Dickson S, McEvoy JP et al. Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. Eur J Hum Genet 2009; 17: 946-957
12. Rujescu D, Ingason A, Cichon S, Pietilainen OP, Barnes MR, Toulopoulou T et al. Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet 2009; 18: 988-996
13. Vrijenhoek T, Buizer-Voskamp JE, van Der Stelt I, Strengman EGenetic R, Outcome in Psychosis Cet al. Recurrent CNVs disrupt three candidate genes in schizophrenia patients. Am J Hum Genet 2008; 83: 504-510
14. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008; 320: 539-543
15. Todarello G, Feng N, Kolachana BS, Li C, Vakkalanka R, Bertolino A et al. Incomplete penetrance of NRXN1 deletions in families with schizophrenia. Schizophr Res 2014; 155: 1-7
16. Souza RP, Meltzer HY, Lieberman JA, Le Foll B, Kennedy JL. Influence of neurexin 1 (NRXN1) polymorphisms in clozapine response. Hum Psychopharmacol 2010; 25: 582-585
17. Lett TA, Tiwari AK, Meltzer HY, Lieberman JA, Potkin SG, Voineskos AN et al. The putative functional rs1045881 marker of neurexin-1 in schizophrenia and clozapine response. Schizophr Res 2011; 132: 121-124
18. Jenkins A, Apud JA, Zhang F, Decot H, Weinberger DR, Law AJ. Identification of candidate single-nucleotide polymorphisms in NRXN1 related to antipsychotic treatment response in patients with schizophrenia. Neuropsychopharmacology 2014; 39: 2170-2178
19. Tansey KE, Rucker JJ, Kavanagh DH, Guipponi M, Perroud N, Bondolfi G et al. Copy number variants and therapeutic response to antidepressant medication in major depressive disorder. Pharmacogenomics J 2014; 14: 395-399
20. Nussbaum J, Xu Q, Payne TJ, Ma JZ, Huang W, Gelernter J et al. Significant association of the neurexin-1 gene (NRXN1) with nicotine dependence in European- and African-American smokers. Hum Mol Genet 2008; 17: 1569-1577
21. Yang J, Wang S, Yang Z, Hodgkinson CA, Iarikova P, Ma JZ et al. The contribution of rare and common variants in 30 genes to risk nicotine dependence. Mol Psychiatry 2014; doi: 10.1038/mp.2014.156; e-pub ahead of print
22. Rowen L, Young J, Birditt B, Kaur A, Madan A, Philipps DL et al. Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. Genomics 2002; 79: 587-597
23. Missler M, Sudhof TC. Neurexins: three genes and 1001 products. Trends Genet 1998; 14: 20-26
24. Tabuchi K, Sudhof TC. Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. Genomics 2002; 79: 849-859
25. Sudhof TC. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 2008; 455: 903-911
26. Graf ER, Zhang X, Jin SX, Linhoff MW, Craig AM. Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell 2004; 119: 1013-1026
27. Song JY, Ichtchenko K, Sudhof TC, Brose N. Neuroligin 1 is a postsynaptic celladhesion molecule of excitatory synapses. Proc Natl Acad Sci USA 1999; 96: 1100-1105
28. Varoqueaux F, Jamain S, Brose N. Neuroligin 2 is exclusively localized to inhibitory synapses. Eur J Cell Biol 2004; 83: 449-456
29. Boucard AA, Chubykin AA, Comoletti D, Taylor P, Sudhof TC. A splice code for trans-synaptic cell adhesion mediated by binding of neuroligin 1 to alpha- and beta-neurexins. Neuron 2005; 48: 229-236
30. Zhang C, Atasoy D, Arac D, Yang X, Fucillo MV, Robison AJ et al. Neurexins physically and functionally interact with GABA(A) receptors. Neuron 2010; 66: 403-416
31. Sun C, Cheng MC, Qin R, Liao DL, Chen TT, Koong FJ et al. Identification and functional characterization of rare mutations of the neuroligin-2 gene (NLGN2) associated with schizophrenia. Hum Mol Genet 2011; 20: 3042-3051
32. Jamain S, Quach H, Betancur C, Rastam M, Colineaux C, Gillberg IC et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 2003; 34: 27-29
33. Law AJ, Lipska BK, Weickert CS, Hyde TM, Straub RE, Hashimoto R et al. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5' SNPs associated with the disease. Proc Natl Acad Sci USA 2006; 103: 6747-6752
34. Kao WT, Wang Y, Kleinman JE, Lipska BK, Hyde TM, Weinberger DR et al. Common genetic variation in Neuregulin 3 (NRG3) influences risk for schizophrenia and impacts NRG3 expression in human brain. Proc Natl Acad Sci USA 2010; 107: 15619-15624
35. Andersen SL. Trajectories of brain development: point of vulnerability or window of opportunity?. Neurosci Biobehav Rev 2003; 27: 3-18
36. Tau GZ, Peterson BS. Normal development of brain circuits. Neuropsychopharmacology 2010; 35: 147-168
37. Huttenlocher PR. Synaptic density in human frontal cortex - developmental changes and effects of aging. Brain Res 1979; 163: 195-205
38. Puschel AW, Betz H. Neurexins are differentially expressed in the embryonic nervous system of mice. J Neurosci 1995; 15: 2849-2856
39. Paraoanu LE, Becker-Roeck M, Christ E, Layer PG. Expression patterns of neurexin-1 and neuroligins in brain and retina of the chick embryo: Neuroligin-3 is absent in retina. Neurosci Lett 2006; 395: 114-117
40. Brown SM, Clapcote SJ, Millar JK, Torrance HS, Anderson SM, Walker R et al. Synaptic modulators Nrxn1 and Nrxn3 are disregulated in a Disc1 mouse model of schizophrenia. Mol Psychiatry 2011; 16: 585-587
41. Rozic-Kotliroff G, Zisapel N. Ca2+ -dependent splicing of neurexin IIalpha. Biochem Biophys Res Commun 2007; 352: 226-230
42. Iijima T, Wu K, Witte H, Hanno-Iijima Y, Glatter T, Richard S et al. SAM68 regulates neuronal activity-dependent alternative splicing of neurexin-1. Cell 2011; 147: 1601-1614
43. Rozic G, Lupowitz Z, Piontkewitz Y, Zisapel N. Dynamic changes in neurexins' alternative splicing: role of Rho-Associated protein kinases and relevance to memory formation. PloS One 2011; 6: e18579
44. Kang Y, Zhang X, Dobie F, Wu H, Craig AM. Induction of GABAergic postsynaptic differentiation by alpha-neurexins. J Biol Chem 2008; 283: 2323-2334
45. Chih B, Gollan L, Scheiffele P. Alternative splicing controls selective trans-synaptic interactions of the neuroligin-neurexin complex. Neuron 2006; 51: 171-178
46. Graf ER, Kang Y, Hauner AM, Craig AM. Structure function and splice site analysis of the synaptogenic activity of the neurexin-1 beta LNS domain. J Neurosci 2006; 26: 4256-4265
47. Siddiqui TJ, Pancaroglu R, Kang Y, Rooyakkers A, Craig AM. LRRTMs and neuroligins bind neurexins with a differential code to cooperate in glutamate synapse development. J Neurosci 2010; 30: 7495-7506
48. Kumar D, Thakur MK. Perinatal exposure to bisphenol-A impairs spatial memory through upregulation of neurexin1 and neuroligin3 expression in male mouse brain. PloS One 2014; 9: e110482
49. Noor A, Lionel AC, Cohen-Woods S, Moghimi N, Rucker J, Fennell A et al. Copy number variant study of bipolar disorder in Canadian and UK populations implicates synaptic genes. Am J Med Genet 2014; 165B: 303-313
50. International Schizophrenia C, Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 460: 748-752